Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.Utility of RNA-seq and GPMDB protein observation frequency for improving the sensitivity of protein identification by tandem MSIdentification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoringQuantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsAdvancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies.The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation.Serum proteomics in biomedical research: a systematic review.Novel approaches for the identification of biomarkers of aggressive prostate cancerProteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Application of clinical proteomics in acute respiratory distress syndrome.
P2860
Q26738703-C70C2877-7C90-473D-8F68-05A91E6917ACQ33567004-5817190B-1634-4325-80D8-6A8CB5AC25E1Q34141742-6CDF4337-8A25-44DB-A7F2-1E602C071586Q34810177-B856D6AA-D4E2-45C8-AA49-843BC70004B2Q34997502-678B7F40-F93B-45D0-B3F3-3BDE5EC6813DQ36031629-ACBC76CA-56BD-439B-99FA-A6547AFFC743Q37972865-54146FE2-C820-44F8-992A-AABD8C7F86DFQ38012171-D911614E-3E3A-4268-8AD8-26D3BB4B060AQ38101008-9BE5698F-21E3-4F55-AA1B-0D27FA034307Q38117841-7DF0803F-D21E-4C82-8EE5-6D06DD9AD40CQ38132914-F750F329-DE9C-4089-A879-3F23C1351C55Q38604366-52567633-2D24-48EF-ABFE-F9B0D06300E1Q42754821-2AD8ED5B-64C6-4A3A-A5A7-89BFCDDBE33E
P2860
Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of selected reacti ...... biomarkers in prostate cancer.
@en
Development of selected reacti ...... biomarkers in prostate cancer.
@nl
type
label
Development of selected reacti ...... biomarkers in prostate cancer.
@en
Development of selected reacti ...... biomarkers in prostate cancer.
@nl
prefLabel
Development of selected reacti ...... biomarkers in prostate cancer.
@en
Development of selected reacti ...... biomarkers in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Development of selected reacti ...... biomarkers in prostate cancer.
@en
P2093
Amjad P Khan
Anastasia K Yocum
Arul M Chinnaiyan
P2860
P304
P356
10.1002/PMIC.201000023
P577
2010-10-01T00:00:00Z